GB202015204D0
|
|
Method for producing genetically modfied cells
|
GB202010689D0
|
|
Methods for genetically modifying calls
|
GB202010692D0
|
|
RNA scaffolds
|
GB201813311D0
|
|
Novel compounds and their use
|
WO2018172798A1
|
|
Argonaute system
|
GB201721453D0
|
|
Argonaute system
|
WO2018096356A1
|
|
Methods for conditional gene knock-out
|
GB201717695D0
|
|
Methods for conditional gene knock-out
|
GB201713990D0
|
|
Materials and methods for treating KRAS mutated cancer
|
GB201713081D0
|
|
The evaluation of guide RNAs in Cells
|
GB201712656D0
|
|
Argonaute system
|
GB201712049D0
|
|
Novel compounds and their use
|
GB201709988D0
|
|
Methods for generating defined mutations
|
GB201705201D0
|
|
Novel compounds and their use as kinase inhibitors
|
GB201704673D0
|
|
Argonaute system
|
GB201620091D0
|
|
Methods for conditional gene knock-out
|
GB201613134D0
|
|
Novel compounds and their use
|
GB201609580D0
|
|
Novel compounds and their use as kinase inhibitors
|
GB201602473D0
|
|
Replicative transposon system
|
GB201518899D0
|
|
Anticancer treatments
|